VRTX Total Liabilities
Vertex Pharmaceuticals · Total Liabilities
VRTX Total Liabilities
Latest reported$7.48Bperiod ending
VRTX FY Total Liabilities ($4.00M → $7.48B)
Annual total liabilities
High-resolution chart · PNG
VRTX total liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 7,477,000,000 | |
| 6,123,600,000 | |
| 5,149,800,000 | |
| 4,238,200,000 | |
| 3,332,500,000 | |
| 3,065,000,000 | |
| 2,233,221,000 | |
| 1,810,695,000 | |
| 1,503,708,000 | |
| 1,558,596,000 | |
| 1,404,959,000 | |
| 1,238,496,000 | |
| 962,636,000 | |
| 1,563,436,000 | |
| 1,275,804,000 | |
| 1,221,473,000 | |
| 859,142,000 | |
| 741,605,000 | |
| 330,182,000 | |
| 415,644,000 | |
| 309,822,000 | |
| 510,012,000 | |
| 531,566,000 | |
| 437,139,000 | |
| 449,780,000 | |
| 427,125,000 | |
| 23,211,000 | |
| 20,100,000 | |
| 19,600,000 | |
| 12,700,000 | |
| 13,700,000 | |
| 10,700,000 | |
| 11,500,000 | |
| 7,100,000 | |
| 4,900,000 | |
| 4,000,000 |